Bayer Stock News

The U.S. Supreme Court asked President Donald Trump's administration on Monday for its views on Bayer's bid to sharply limit lawsuits claiming that the company's Roundup weedkiller causes cancer and potentially avert billions of dollars in damages.

Bayer said on Monday that the U.S. Supreme Court had asked the solicitor general for an opinion in the Durnell case, as the German company seeks clarity from the top U.S. court in litigation related to its weedkiller glyphosate.

Bayer DE000BAY0017 muss sich mit Blick auf eine wegweisende Entscheidung des obersten US-Gerichts in den Rechtsstreitigkeiten um den Unkrautvernichter Glyphosat gedulden.

Bayer DE000BAY0017 muss sich mit Blick auf eine wegweisende Entscheidung des obersten US-Gerichts in den Rechtsstreitigkeiten um den Unkrautvernichter Glyphosat gedulden.

Die Privatbank Berenberg hat Bayer DE000BAY0017 auf "Hold" mit einem Kursziel von 26 Euro belassen.

Bayer share price has bounced back this year, making it one of the best-performing companies in the German DAX Index. It has jumped to €26, up by 45% from its lowest point this year.

Prestigious International Annual Awards Program Honors Standout AI Companies & Solutions Prestigious International Annual Awards Program Honors Standout AI Companies & Solutions

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational contrast agent gadoquatrane for contrast-enhanced magnetic resonance imaging of the CNS and other body regions in adults and pediatric patients including term neonates. The submitted dose is 0.04 mmol gadolinium per kilogram b...